Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Mura

Showing results (1-10 of 184) with videos related to

Pageof 19
Sort By:
The European Respiratory Journal|June 2, 2014
6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosisMarco Mura
Pulmonary Pharmacology & Therapeutics|January 2, 2021
Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: much caution is warrantedMarco Mura
Pulmonary Pharmacology & Therapeutics|March 22, 2021
Corrigendum to "Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: Much caution is warranted" [Pulm. Pharmacol. 66 (2021 Feb) 101987]Marco Mura
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
Multi-dimensional indices to stage idiopathic pulmonary fibrosis: a systematic reviewCamilla Rozanski, Marco Mura
American Journal of Ophthalmology|June 3, 2014
Metamorphopsia and optical coherence tomography findings after rhegmatogenous retinal detachment surgeryRoberto dell'Omo, Marco Mura
Developments in Ophthalmology|September 9, 2014
Intraocular optical coherence tomographyMarco Mura, Francesco Barca
Developments in Ophthalmology|September 9, 2014
25-Gauge vitrectomyMarco Mura, Francesco Barca
Respiration; International Review of Thoracic Diseases|April 13, 2021
Exercise Testing in Idiopathic Pulmonary Fibrosis: Expanding Our OptionsMarco Mura, Demosthenes Bouros
Respirology (Carlton, Vic.)|November 19, 2016
A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung diseaseHadeel Khadawardi, Marco Mura
Respirology (Carlton, Vic.)|April 21, 2019
Bronchiolitis obliterans syndrome as manifestation of lung GVHD: Not the only oneMarco Mura, Stephen Juvet
Pageof 19

Showing results (1-10 of 184) with videos related to

Sort By:
Pageof 19
The European Respiratory Journal|June 2, 2014
6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosisMarco Mura
Pulmonary Pharmacology & Therapeutics|January 2, 2021
Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: much caution is warrantedMarco Mura
Pulmonary Pharmacology & Therapeutics|March 22, 2021
Corrigendum to "Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: Much caution is warranted" [Pulm. Pharmacol. 66 (2021 Feb) 101987]Marco Mura
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
Multi-dimensional indices to stage idiopathic pulmonary fibrosis: a systematic reviewCamilla Rozanski, Marco Mura
American Journal of Ophthalmology|June 3, 2014
Metamorphopsia and optical coherence tomography findings after rhegmatogenous retinal detachment surgeryRoberto dell'Omo, Marco Mura
Developments in Ophthalmology|September 9, 2014
Intraocular optical coherence tomographyMarco Mura, Francesco Barca
Developments in Ophthalmology|September 9, 2014
25-Gauge vitrectomyMarco Mura, Francesco Barca
Respiration; International Review of Thoracic Diseases|April 13, 2021
Exercise Testing in Idiopathic Pulmonary Fibrosis: Expanding Our OptionsMarco Mura, Demosthenes Bouros
Respirology (Carlton, Vic.)|November 19, 2016
A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung diseaseHadeel Khadawardi, Marco Mura
Respirology (Carlton, Vic.)|April 21, 2019
Bronchiolitis obliterans syndrome as manifestation of lung GVHD: Not the only oneMarco Mura, Stephen Juvet
Pageof 19